Neuralink founder Elon Musk announced on X that the first human brain chip implant has given promising results. The US Food and Drug Administration (FDA) had earlier permitted them to conduct this implant trial on humans. Musk tweeted on Monday,
He said Neuralink would name its first product Telepathy. As per Musk, Telepathy will allow you to have “control of your phone or computer, and through them almost any device, just by thinking.” He added, “Initial users will be those who have lost the use of their limbs.” Notably, he also mentioned the late theoretical physicist and scientist Stephen Hawking and said, “Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal.”
Musk co-founded this neurotechnology company in 2016 to help maintain conversation between the brain and computer. It will hopefully treat neurological disorders such as ALS and Parkinson’s and establish a relationship between humans and artificial intelligence.
The Neuralink website names the study PRIME, which stands for Precise Robotically Implanted Brain-Computer Interface. “A groundbreaking investigational medical device trial for our fully implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for enabling people with paralysis to control external devices with their thoughts,” the website added.
The US Department of Transportation (DoT) fined Neuralink for violating rules by transporting and improperly packing hazardous products. However, the company achieved its first human implant after FDA clearance. Neuralink initially announced in September that the R1 Robot will surgically place the N1 Implant’s ultra-fine, flexible threads in the brain region controlling movement intention.
Active Noon Media is the largest local to national digital media website that represents the voice of the entire nation.